Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus. 2002

R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
Atatürk University, Erzurum, Turkey. refikali@yahoo.com

Systemic lupus erythematosus (SLE) is a classic autoimmune disease characterised by the production of autoreactive T cells and autoantibodies that may affect every organ system. It has long been established that there is a close association between cholesterol- rich lipoproteins (such as low-density lipoprotein-cholesterol) and cardiovascular disease in patients with SLE. In this study, we evaluated total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, VLD-cholesterol, apolipoprotein A-1, apolipoprotein B, and cholesterol-rich serum lipoprotein(a) [Lp(a)], which is accepted to be an independent risk factor for cardiovascular disease and for atherosclerosis, in 24 patients (mean age +/- SD 31.4 +/- 9.7 years, range 16-47, 22 F) with active SLE. Twenty-six healthy age- and sex-matched (mean age +/- SD 29.7 +/- 11.3 years, range 18-49 years, 22 F) subjects were included as a control group. In patients with SLE Lp(a) levels, total cholesterol, triglycerides and VLDL-cholesterol were found to be higher and HDL-cholesterol, apolipoprotein A-1 to be lower than those of controls. In conclusion, because serum Lp(a) levels are significantly higher (P<0.01) in patients with SLE, these patients have a risk of developing cardiovascular disease and atherosclerosis. Patients with SLE should be followed up with this in mind.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein

Related Publications

R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
January 1996, Clinical and experimental rheumatology,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
April 1988, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
February 1970, Naika. Internal medicine,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
April 2012, Chinese medical journal,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
April 2010, Journal of internal medicine,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
February 1993, Ryumachi. [Rheumatism],
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
August 1991, Annals of the rheumatic diseases,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
January 1980, Terapevticheskii arkhiv,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
January 1994, Thrombosis research,
R A Sari, and M F Polat, and S Taysi, and E Bakan, and I Capoğlu
June 2018, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Copied contents to your clipboard!